Kestra Medical Technologies, Ltd. Revenue 2024–2025
Kestra Medical Technologies, Ltd. annual/quarterly revenue history and growth rate from 2024 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Kestra Medical Technologies, Ltd. revenue for the quarter ending January 31, 2026 was 24.6 M, a 62.70% increase year-over-year.
- Kestra Medical Technologies, Ltd. revenue for the twelve months ending January 31, 2026 was 81.6 M.
- Kestra Medical Technologies, Ltd. annual revenue for 2025 was 59.8 M, a 115.05% increase from 2024.
- Kestra Medical Technologies, Ltd. annual revenue for 2024 was 27.8 M.
Kestra Medical Technologies, Ltd. (KMTS) — Frequently Asked Questions
Kestra Medical Technologies, Ltd. (KMTS) is a publicly traded US company. It has a market capitalization of $488M. In fiscal 2025 it reported revenue of $60M and net income of -$114M. Explore KMTS's stock price, financial statements, earnings history, margins and key ratios below.
What is Kestra Medical Technologies, Ltd.'s market cap?
Kestra Medical Technologies, Ltd. (KMTS) has a market capitalization of $488M.
What is the KMTS stock price?
KMTS trades at $19.85 (+2.11% on the day).
How much revenue does Kestra Medical Technologies, Ltd. make?
Kestra Medical Technologies, Ltd. reported revenue of $60M in fiscal 2025.
Is KMTS profitable?
In fiscal 2025, Kestra Medical Technologies, Ltd. reported net income of -$114M.